Pharmareg Consulting Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 05619969 (England and Wales)

FINANCIAL STATEMENTS

FOR THE PERIOD 1 DECEMBER 2019 TO 31 MARCH 2021

FOR

PHARMAREG CONSULTING LIMITED

Page

Company Information

1

Chartered Accountants' Report

2

Statement of Financial Position

3

DIRECTOR:

Mr A K Malhotra

REGISTERED OFFICE:

505 Pinner Road

Harrow

Middlesex

HA2 6EH

REGISTERED NUMBER:

05619969 (England and Wales)

ACCOUNTANTS:

STGCA LLP t/a Sterling

Chartered Accountants

505 Pinner Road

Harrow

Middlesex

HA2 6EH

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Statement of Financial Position. Readers are cautioned that the Income Statement is not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Pharmareg Consulting Limited for the period ended 31 March 2021 which comprise the Income Statement, Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Pharmareg Consulting Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Pharmareg Consulting Limited and state those matters that we have agreed to state to the director of Pharmareg Consulting Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Pharmareg Consulting Limited and its director for our work or for this report.

It is your duty to ensure that Pharmareg Consulting Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Pharmareg Consulting Limited. You consider that Pharmareg Consulting Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Pharmareg Consulting Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

STGCA LLP t/a Sterling

Chartered Accountants

505 Pinner Road

Harrow

Middlesex

HA2 6EH

30 November 2021

FIXED ASSETS

93,046

17,102

CURRENT ASSETS

342,941

167,597

CREDITORS

Amounts falling due within one year

(101,304

)

(54,229

)

NET CURRENT ASSETS

241,637

113,368

TOTAL ASSETS LESS CURRENT LIABILITIES

334,683

130,470

CREDITORS

Amounts falling due after more than one year

106,051

-

NET ASSETS

228,632

130,470

CAPITAL AND RESERVES

228,632

130,470

NOTES TO THE FINANCIAL STATEMENTS

1.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 1 (2019 - 1 ) .

2.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

During the period the company paid dividends of £2,000 (2019: £28,800) to the director.

At the period end the director owed £121,396 (2019: £56,739) to the company. The amount owed is repayable on demand. The company charged interest on the amount due from the director at the rate of 2.50% per annum.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2021.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2021 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 30 November 2021 and were signed by:

Mr A K Malhotra - Director